Concurrent Session 1B: Opioid Prescribing: Clinical Realities
Tracks
.
| Monday, November 9, 2026 |
| 1:30 PM - 3:00 PM |
Speaker
Ms Lucy Tran
PhD Candidate, Research Officer
NDARC
Co-occurring mental disorders and retention in buprenorphine and methadone treatment for opioid use disorder: A retrospective data linkage cohort study
1:35 PM - 1:45 PMBiography
Lucy Tran (BSci, BPsySc(Hons), MClinPsy) has worked across multiple projects examining the risks and harms associated with different illicit drug use and dependence. Lucy is a Clinical Psychologist and PhD candidate, with her PhD exploring the association of mental disorders on treatment outcomes among people dependent on methamphetamine or opioids.
Mr. Nicholas Kent
Policy & Advocacy Manager
Harm Reduction Victoria
Facilitating a lived & living experience review of opioid dependence treatment in Victoria
1:55 PM - 2:05 PMBiography
Nick Kent is an advocate working in harm reduction and drug policy reform, with a background in education and policy studies. Nick works on reform projects at state, national and international leves, and works with diverse communities of people who use drugs in community peer education, research and advocacy.
Professor Paul Dietze
Co_director, Disease Elimination Program
Burnet Institute
The relationship between opioid agonist therapy and reduced injecting frequency amongst people who inject drugs: Evidence from a prospective cohort study
2:05 PM - 2:15 PMBiography
Professor Dietze is one of Australia's leading alcohol and other drug years' with over 30 years' experience in the field.
Professor Michael Doyle
Head Of First Nations Health Research
Edith Collins Centre, The University Of Sydney
Zones of abandonment: Understanding LAIB discontinuation among Aboriginal people after release from custody
2:25 PM - 2:35 PMBiography
Professor Michael Doyle is a Bardi Man and a research-focused academic at the University of Sydney. He has worked in Aboriginal health for over 20 years, commencing his career as an Aboriginal Health Worker at the Broome Regional Aboriginal Medical Service. Michael moved into Aboriginal health research in 2008 and utilises a mixed-methods approach in his work. Presently, Michael is the Head of the First Nations health team at the Edith Collins Centre for translational research in alcohol, drugs, and toxicology. His research aims to improve health service delivery for Aboriginal and Torres Strait Islander people who use alcohol and/or other drugs. Michael's research also has a focus on improving health service delivery for those in the criminal justice system. Michael is an active member of the Aboriginal community and has served on Aboriginal community-controlled organisation boards. He served as co-chair of the Aboriginal Health and Medical Research Council of NSW's Human Research Ethics Committee 2021 to 2026 (May).
Dr Natasha Hall
Research Fellow
Eastern Health
Geographic and socioeconomic inequities in access to opioid agonist treatment in Australia
2:35 PM - 2:40 PMBiography
Dr Hall is a pharmacist and Early Career Research Fellow in the Health Economics Group at Monash University and Turning Point, Eastern Health, who works in health economics and health services research in substance use, addiction and mental health.
Professor Paul Dietze
Co_director, Disease Elimination Program
Burnet Institute
